Müller H, Kirkhus B, Pedersen J I
University College of Akershus, Bekkestua, Norway.
Lipids. 2001 Aug;36(8):783-91. doi: 10.1007/s11745-001-0785-6.
The effects of dietary trans fatty acids on serum total and low density lipoprotein (LDL) cholesterol have been evaluated by incorporating trans fatty acids into predictive equations and comparing their effects with the effects of the individual saturated fatty acids 12:0, 14:0, and 16:0. Trans fatty acids from partially hydrogenated soybean oil (TRANS V) and fish oil (TRANS F) were included in previously published equations by constrained regression analysis, allowing slight adjustments of existing coefficients. Prior knowledge about the signs and ordering of the regression coefficients was explicitly incorporated into the regression modeling by adding lower and upper bounds to the coefficients. The amounts of oleic acid (18:1) and polyunsaturated fatty acids (18:2, 18:3) were not sufficiently varied in the studies, and the respective regression coefficients were therefore set equal to those found by Yu et al. [Yu, S., Derr, J., Etherton, T.D., and Kris-Etherton, P.M. (1995) Plasma Cholesterol-Predictive Equations Demonstrate That Stearic Acid Is Neutral and Monounsaturated Fatty Acids Are Hypocholesterolemic, Am. J. Clin. Nutr. 61, 1129-1139]. Stearic acid (18:0), considered to be neutral, was not included in the equations. The regression analyses were based on results from four controlled dietary studies with a total of 95 participants and including 10 diets differing in fatty acid composition and with 30-38% of energy (E%) as fat. The analyses resulted in the following equations, where the change in cholesterol is expressed in mmol/L and the change in intake of fatty acids is expressed in E%: delta Total cholesterol = 0.01 delta(12:0) + 0.12 delta(14:0) + 0.057 delta(16:0) + 0.039 delta(TRANS F) + 0.031 delta(TRANS V) - 0.0044 delta(18:1) - 0.017 delta(18:2, 18:3) and deltaLDL cholesterol = 0.01 delta(12:0) + 0.071 delta(14:0) + 0.047 delta(16:0) + 0.043 delta(TRANS F) + 0.025 delta(TRANS V) - 0.0044 delta(18:1) - 0.017 delta(18:2, 18:3). The regression analyses confirm previous findings that 14:0 is the most hypercholesterolemic fatty acid and indicate that trans fatty acids are less hypercholesterolemic than the saturated fatty acids 14:0 and 16:0. TRANS F may be slightly more hypercholesterolemic than TRANS V or there may be other hypercholesterolemic fatty acids in partially hydrogenated fish oil than those included in the equations. The test set used for validation consisted of 22 data points from seven recently published dietary studies. The equation for total cholesterol showed good prediction ability with a correlation coefficient of 0.981 between observed and predicted values. The equation has been used by the Norwegian food industry in reformulating margarines into more healthful products with reduced content of cholesterol-raising fatty acids.
通过将反式脂肪酸纳入预测方程,并将其效果与单个饱和脂肪酸12:0、14:0和16:0的效果进行比较,评估了膳食反式脂肪酸对血清总胆固醇和低密度脂蛋白(LDL)胆固醇的影响。通过约束回归分析,将部分氢化大豆油(TRANS V)和鱼油(TRANS F)中的反式脂肪酸纳入先前发表的方程中,对现有系数进行了微调。通过给系数添加下限和上限,将关于回归系数的符号和排序的先验知识明确纳入回归模型。在这些研究中,油酸(18:1)和多不饱和脂肪酸(18:2、18:3)的含量变化不足,因此将各自的回归系数设定为与Yu等人[Yu, S., Derr, J., Etherton, T.D., and Kris-Etherton, P.M. (1995) Plasma Cholesterol-Predictive Equations Demonstrate That Stearic Acid Is Neutral and Monounsaturated Fatty Acids Are Hypocholesterolemic, Am. J. Clin. Nutr. 61, 1129-1139]所发现的系数相等。被认为是中性的硬脂酸(18:0)未包含在方程中。回归分析基于四项对照饮食研究的结果,共有95名参与者,包括10种脂肪酸组成不同的饮食,脂肪提供30 - 38%的能量(E%)。分析得出以下方程,其中胆固醇的变化以mmol/L表示,脂肪酸摄入量的变化以E%表示:总胆固醇变化量 = 0.01×(12:0)变化量 + 0.12×(14:0)变化量 + 0.057×(16:0)变化量 + 0.039×(TRANS F)变化量 + 0.031×(TRANS V)变化量 - 0.0044×(18:1)变化量 - 0.017×(18:2, 18:3)变化量;低密度脂蛋白胆固醇变化量 = 0.01×(12:0)变化量 + 0.071×(14:0)变化量 + 0.047×(16:0)变化量 + 0.043×(TRANS F)变化量 + 0.025×(TRANS V)变化量 - 0.0044×(18:1)变化量 - 0.017×(18:2, 18:3)变化量。回归分析证实了先前的发现,即14:0是最具高胆固醇血症作用的脂肪酸,并表明反式脂肪酸的高胆固醇血症作用低于饱和脂肪酸14:0和16:0。TRANS F的高胆固醇血症作用可能比TRANS V略高,或者部分氢化鱼油中可能存在比方程中包含的其他具有高胆固醇血症作用的脂肪酸。用于验证的测试集由来自七项最近发表的饮食研究的22个数据点组成。总胆固醇方程显示出良好的预测能力,观测值与预测值之间的相关系数为0.981。该方程已被挪威食品工业用于将人造黄油重新配方为胆固醇升高脂肪酸含量降低的更健康产品。